Links + Resources
Below are links to clinical studies and reputable organizations that may be helpful as you consider psychedelics for therapeutic use. This information provided is meant to be used for educational purposes only. It should not be considered medical advice. As always, it is up to the individual to conduct their own due diligence and consult with their healthcare professional to minimize any risks.

Psychedelic Research for Mental Health
Robin Carhart-Harris
Neural correlates of the psychedelic state as determined by fMRI with psilocybin
Carhart-Harris RL, et al. (2012) — PNAS
🔗 https://pubmed.ncbi.nlm.nih.gov/22308440/
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelics
Carhart-Harris RL, et al. (2014) — Frontiers in Human Neuroscience
🔗 https://www.frontiersin.org/articles/10.3389/fnhum.2014.00020/full
Psychedelics and the essential importance of context
Carhart-Harris RL, et al. (2018) — Journal of Psychopharmacology
🔗 https://journals.sagepub.com/doi/10.1177/0269881118754710
Trial of psilocybin vs. escitalopram for depression
Carhart-Harris RL, Nutt DJ, et al. (2021) — New England Journal of Medicine
🔗 https://www.nejm.org/doi/full/10.1056/NEJMoa2032994
Neuroplasticity and psychedelics: a comprehensive examination
Agnorelli C, Carhart-Harris RL, Nutt DJ, et al. (2024) — Preprint / Review
🔗 https://arxiv.org/abs/2411.19840
David J Nutt
Co-author on the psilocybin vs. escitalopram trial (NEJM, 2021):
🔗 https://www.nejm.org/doi/full/10.1056/NEJMoa2032994
Co-author on "Neuroplasticity and psychedelics" review (arXiv, 2024):
🔗 https://arxiv.org/abs/2411.19840
Bill Richards
Therapist training and group protocols for psilocybin-assisted therapy in cancer patients
🔗 https://www.sunstonetherapies.com/team/bill-richards-ph-d/
Sacred Knowledge: Psychedelics and Religious Experiences
Book by William A. Richards — Columbia University Press
🔗 https://spiritplantmedicine.com/william-richards-ph-d/
Additional Key Readings
The therapeutic potential of psychedelic drugs: past, present, and future
Carhart-Harris RL, Goodwin GM (2017) — Neuropsychopharmacology
🔗 https://www.nature.com/articles/npp201711
REBUS and the Anarchic Brain: Toward a unified model of psychedelic action
Carhart-Harris RL, Friston KJ (2019) — Pharmacological Reviews
🔗 https://pharmrev.aspetjournals.org/content/71/3/316
Psychiatric risks for worsened mental health after psychedelic use
Marrocu A, Carhart-Harris RL, et al. (2024) — Journal of Psychopharmacology
🔗 https://journals.sagepub.com/doi/10.1177/02698811241232548
Ketamine
Ketamine Research Foundation – Clinical Guidelines
Guidelines for therapeutic use, safety considerations, and integration support.
🔗https://ketamineresearchfoundation.org
Oxford Health NHS – Ketamine for Depression: Benefits & Risks
A helpful overview from a clinical provider in the UK.
🔗 https://www.oxfordhealth.nhs.uk/ips/ketamine-trd/risks-benefits
Veterans Affairs Ketamine Clinical Review
Guidance for ketamine infusions in VA medical settings.
🔗 VA Guidance on Ketamine Treatments for Depression
American Psychiatric Association
"Ketamine: Miracle Drug or Double-Edged Sword?"
🔗 https://www.psychiatryonline.org
NIH – Ketamine’s Role in Neuroplasticity & Depression
Recent studies on ketamine’s effect on synaptic growth and treatment-resistant depression.
🔗 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910398
Health Psychology Research
"Role of Ketamine in the Treatment of Psychiatric Disorders"